SLAMF6 and neoplasm: Furthermore, Eisenberg et al. reported that the use of the soluble ectodomain of SLAMF6 which enhances receptor dephosphorylation reduced activation-induced cell death, increased IFN-γ production and cytotoxicity in tumor-specific CD8 T cells, resulting in improved tumor control in preclinical models of melanoma39.